Skip to main content

Advertisement

SpringerLink
Log in

Fluoroquinolone-induced liver injury: three new cases and a review of the literature

  • Review Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Fluoroquinolones are popular and widely used in primary care and hospital settings. Premarketing studies showed a favourable side-effect profile. However, significant morbidity and the need for liver transplantation for acute liver failure have been reported. We reviewed the available data on liver damage linked to fluoroquinolones.

Methods

A systematic search of case reports on the MEDLINE database encompassing the years 2000–2011 was carried out. Additional references were found by a manual search of the retrieved paper. We also describe three new cases of hepatotoxicity attributable to fluoroquinolones seen at our Unit.

Results

Thirty-five cases were retrieved from MEDLINE (51.4% male). According to the RUCAM scale, liver injury was classified as hepatocellular (51.4%), cholestatic (28.6%) or mixed (20.0%). Older age (≥ 65 years) was present in 42.8%. The time between initiation of treatment and hepatic injury ranged from 1 to 39 days (median 8 days). According to the RUCAM score, our cases were classified to be “highly probable” or “probable”. Only one patient underwent liver biopsy, which showed the features of liver damage linked to drug exposure. Liver enzymes from all patients return to normal range within 4 weeks of withdrawal. Only one patient showed a renal failure, associated with liver injury, with a need for haemodialysis for 3 weeks.

Conclusions

Fluoroquinolones are substantially safe antibiotics. Although fluoroquinolone-related hepatic injury occurs infrequently, its consequences can be severe. Patients should also be cautioned to avoid re-exposure to other members of the fluoroquinolone class.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Desarro A, Desarro G (2001) Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr Med Chem 8:371–384

    CAS  Google Scholar 

  2. Lapi F, Tuccori M, Motola D et al (2010) Safety profile of the fluoroquinolones. Analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf 33:789–799

    Article  PubMed  CAS  Google Scholar 

  3. Mehlhorn AJ, Brown DA (2007) Safety concerns with fluoroquinolones. Ann Pharmacother 41:1859–1866

    Article  PubMed  Google Scholar 

  4. Gruppo di lavoro OsMed (2010) L’uso dei farmaci in Italia. Rapporto Nazionale. Roma: Il pensiero scientifico editore 2011

  5. Polson JE (2007) Hepatotoxicity due to antibiotics. Clin Liver Dis 11:549–561

    Article  PubMed  Google Scholar 

  6. Andrade RJ, Tulkens PM (2011) Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother 66:1431–1446

    Article  PubMed  CAS  Google Scholar 

  7. George DK, Crawford DH (1996) Antibacterial-induced hepatotoxicity. Incidence, prevention and management. Drug Saf 15:79–85

    Article  PubMed  CAS  Google Scholar 

  8. Andrade RJ, Lucena MI, Fernandez MC et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521

    PubMed  Google Scholar 

  9. Nori S, Nebesio C, Brashear R et al (2004) Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. Arch Dermatol 140:1537–1538

    Article  PubMed  Google Scholar 

  10. Grassmick BK, Lehr VT, Sundareson AS (1992) Fulminant hepatic failure possibly related to ciprofloxacin. Ann Pharmacother 26:636–639

    PubMed  CAS  Google Scholar 

  11. Fuchs S, Simon Z, Brezis M (1994) Fatal hepatic failure associated with ciprofloxacin. Lancet 343:738–739

    Article  PubMed  CAS  Google Scholar 

  12. Spahr L, Rubbia-Brandt L, Marinescu O et al (2001) Acute fatal hepatitis related to levofloxacin. J Hepatol 35:308–309

    Article  PubMed  CAS  Google Scholar 

  13. Thiim M, Friedman LS (2003) Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis 7:381–399

    Article  PubMed  Google Scholar 

  14. Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323–1330

    Article  PubMed  CAS  Google Scholar 

  15. Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245

    Article  PubMed  CAS  Google Scholar 

  16. García-Cortés M, Lucena MI, Pachkoria K, for the Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatias Asociadas a Medicamentos, Geham) et al (2008) Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 27:780–789

    Article  PubMed  Google Scholar 

  17. Orman ES, Conjeevaram HS, Vuppalanchi R et al (2011) Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clin Gastroenterol Hepatol 9:517–523

    Article  PubMed  Google Scholar 

  18. Alan C, Koçoğlu H, Ersay AR et al (2011) Unexpected severe hepatotoxicity of ciprofloxacine: two case reports. Drug Chem Toxicol 34:189–191

    Article  PubMed  CAS  Google Scholar 

  19. Titos-Arcos JC, Hallal H, Robles M et al (2011) Acute cholestatic hepatitis associated with levofloxacin. Gastroenterol Hepatol 34:369–370

    Article  PubMed  Google Scholar 

  20. Figueira-Coelho J, Pereira O, Picado B et al (2010) Acute hepatitis associated with the use of levofloxacin. Clin Ther 32:1733–1737

    Article  PubMed  Google Scholar 

  21. Cholongitas E, Georgousaki C, Spyrou S et al (2009) Ciprofloxacin-induced acute cholestatic hepatitis. Ann Hepatol 8:400–401

    PubMed  Google Scholar 

  22. Carrascosa MF, Lucena MI, Andrade RJ et al (2009) Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther 31:1014–1019

    Article  PubMed  Google Scholar 

  23. García-Aparicio J, Herrero-Herrero JI (2010) Toxic hepatitis following sequential treatment with cotrimoxazol, levofloxacin, doxycycline and sertraline in a patient with a respiratory infection. Farm Hosp 34:152–154

    Article  PubMed  Google Scholar 

  24. Verma R, Dhamija R, Batts DH et al (2009) Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report. Cases J 2:8063

    Article  PubMed  Google Scholar 

  25. Dichiara AJ, Atkinson M, Goodman Z et al (2008) Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Minerva Gastroenterol Dietol 54:307–315

    PubMed  CAS  Google Scholar 

  26. Bhagirath KM (2008) A case report of highly suspected ciprofloxacin-induced hepatotoxicity. Turk J Gastroenterol 19:204–206

    PubMed  Google Scholar 

  27. Okan G, Yaylaci S, Peker O et al (2008) Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol 14:4697–4700

    Article  PubMed  Google Scholar 

  28. Coban S, Ceydilek B, Ekiz F et al (2005) Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection. Ann Pharmacother 39:1737–1740

    Article  PubMed  Google Scholar 

  29. Zimpfer A, Propst A, Mikuz G et al (2004) Ciprofloxacin-induced acute liver injury: case report and review of literature. Virchows Arch 444:87–89

    Article  PubMed  Google Scholar 

  30. Goetz M, Galle PR, Schwarting A (2003) Non-fatal acute liver injury possibly related to high-dose ciprofloxacin. Eur J Clin Microbiol Infect Dis 22:294–296

    PubMed  CAS  Google Scholar 

  31. Schwalm JD, Lee CH (2003) Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. CMAJ 168:847–848

    PubMed  Google Scholar 

  32. Airey KJ, Koller E (2003) Acute hepatitis associated with levaquin in a patient with renal insufficiency taking amiodarone. CMAJ 14:169

    Google Scholar 

  33. Bataille L, Rahier J, Geubel A (2002) Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease. J Hepatol 37:696–699

    Article  PubMed  Google Scholar 

  34. Soto S, López-Rosés L, Avila S et al (2002) Moxifloxacin-induced acute liver injury. Am J Gastroenterol 97:1853–1854

    Article  PubMed  Google Scholar 

  35. Contreras MA, Luna R, Mulero J et al (2001) Severe ciprofloxacin-induced acute hepatitis. Eur J Clin Microbiol Infect Dis 20:434–435

    Article  PubMed  CAS  Google Scholar 

  36. Karim A, Ahmed S, Rossoff LJ (2001) Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease. Clin Infect Dis 33:2088–2090

    Article  PubMed  CAS  Google Scholar 

  37. Nakamae H, Hino M, Yamane T (2000) A case of rhabdomyolysis due to levofloxacin. Clin Drug Invest 20:203–205

    Article  Google Scholar 

  38. Björnsson E, Olsson R (2000) Norfloxacin-induced eosinophilic necrotizing granulomatous hepatitis. Am J Gastroenterol 95:3662–3663

    PubMed  Google Scholar 

  39. Iannini PB (2007) The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Curr Med Res Opin 23:1403–1413

    Article  PubMed  CAS  Google Scholar 

  40. O’Donnell JA, Gelone SP (2000) Fluoroquinolones. Infect Dis Clin North Am 14:489–513

    Article  PubMed  Google Scholar 

  41. De Valle MB, Av Klinteberg V, Alem N et al (2006) Drug induced liver injury in a Swedish university hospital out-patient hepatology clinic. Aliment Pharmacol Ther 24:1187–1195

    Article  PubMed  Google Scholar 

  42. Van Bambeke F, Tulkens PM (2009) Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 32:359–378

    Article  PubMed  Google Scholar 

  43. Chalasani N, Björnsson E (2010) Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 138:2246–2259

    Article  PubMed  CAS  Google Scholar 

  44. Aithal GP, Day CP (2007) Nonsteroidal anti-inflammatory drug induced hepatotoxicity. Clin Liver Dis 11:563–575

    Article  PubMed  Google Scholar 

  45. Larson AM (2007) Acetaminophen hepatotoxicity. Clin Liver Dis 11:525–548

    Article  PubMed  Google Scholar 

  46. Elouni B, Ben Salem C, Zamy M (2010) Cytolytic hepatitis possibly related to levonorgestrel/ethinylestradiol oral contraceptive use: 2 case reports. Ann Pharmacother 44:2035–2037

    Article  PubMed  Google Scholar 

  47. Wolfson JS, Hooper DC (1991) Overview of fluoroquinolone safety. Am J Med 91:153–161

    Article  Google Scholar 

  48. Liu HH (2010) Safety profile of the fluoroquinolones. Focus on levofloxacin. Drug Saf 33:353–369

    Article  PubMed  CAS  Google Scholar 

  49. Owens RC, Ambrose PG (2005) Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41 [Suppl 2]:S144–S157

    Article  PubMed  CAS  Google Scholar 

  50. Jones SE, Smith RH (1997) Quinolones may induce hepatitis. BMJ 314:869

    Article  PubMed  CAS  Google Scholar 

  51. Hautekeete ML, Kockx MM, Naegels S et al (1995) Cholestatic hepatitis related to quinolones: a report of two cases. J Hepatol 23:759–760

    Article  PubMed  CAS  Google Scholar 

  52. Blum A (1991) Ofloxacin-induced acute severe hepatitis. South Med J 84:1158

    Article  PubMed  CAS  Google Scholar 

  53. EMEA/CHMP (issued 24/07/08) European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines. http://www.emea.europa.eu/pdfs/human/press/pr/38292708en.pdf

  54. Lopez-Navidad A, Domingo P, Cadafalch J et al (1990) Norfloxacin-induced hepatotoxicity. J Hepatol 11:277–278

    Article  PubMed  CAS  Google Scholar 

  55. Davoren P, Mainstone K (1993) Norfloxacin-induced hepatitis. Med J Aust 159:423–426

    PubMed  CAS  Google Scholar 

  56. Lucena MI, Andrade RJ, Sánchez-Martinez H et al (1998) Norfloxacin-induced cholestatic jaundice. Am J Gastroenterol 93:2309–2311

    Article  PubMed  CAS  Google Scholar 

  57. Romero-Gómez M, Suárez García E, Fernández MC (1999) Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis. Am J Gastroenterol 94:2324–2325

    Article  PubMed  Google Scholar 

  58. Henann NE, Zambie MF (2001) Gatifloxacin-associated acute hepatitis. Pharmacotherapy 21:157–182

    Article  Google Scholar 

  59. Ball P, Mandell L, Niki Y et al (1999) Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf 21:407–421

    Article  PubMed  CAS  Google Scholar 

  60. Bertino J Jr, Fish D (2000) The safety profile of the fluoroquinolones. Clin Ther 22:798–817

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sezione e U.O.C. di Gastroenterologia, Di.Bi.M.I.S, Università di Palermo, Palermo, Italy

    Anna Licata, Claudia Randazzo, Giuseppe Butera & Antonio Craxì

  2. Sezione di Farmacologia, Dipartimento di Scienze per la promozione della Salute, Università di Palermo, Palermo, Italy

    Ilaria Morreale & Natale D’Alessandro

  3. Sezione di Gastroenterologia & Epatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, Università di Palermo, Piazza Delle Cliniche 2, 90127, Palermo, Italy

    Anna Licata

Authors
  1. Anna Licata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Randazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilaria Morreale
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Butera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Natale D’Alessandro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antonio Craxì
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Licata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Licata, A., Randazzo, C., Morreale, I. et al. Fluoroquinolone-induced liver injury: three new cases and a review of the literature. Eur J Clin Pharmacol 68, 525–532 (2012). https://doi.org/10.1007/s00228-011-1201-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1201-6

Keywords

Search

Navigation